Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Recent advances in molecular biology and cytogenetics have made it possible to localize, clone, and characterize some of the genetic abnormalities that result in the hypoparathyroid disorders. Mutations in the parathyroid hormone gene and in the mitochondrial genome have been demonstrated to be associated with some forms of hypoparathyroidism, and mutations in the Gsα gene occur in some patients with pseudohypoparathyroidism; moreover, candidate genes for the DiGeorge syndrome have been identified. In addition, mutations in the calcium-sensing receptor gene have been reported in an autosomal dominant form of hypoparathyroidism. The gene for X-linked recessive hypoparathyroidism, a condition in which parathyroid gland development appears to be defective, has been located on Xq26-Xq27, and genes for a certain form of the DiGeorge syndrome have been located on chromosome 10p. These studies in molecular genetics have provided an opportunity to elucidate the pathogenesis of a widening spectrum of hypoparathyroid states. © 1997 Rapid Science Publishers.

Original publication

DOI

10.1097/00060793-199712000-00008

Type

Journal article

Journal

Current Opinion in Endocrinology and Diabetes

Publication Date

01/01/1997

Volume

4

Pages

427 - 432